Faster Go/No-Go

Decisions

The Food and Drug Administration requires all human pharmaceuticals and medical devices diagnostics to be tested on animals prior to human trials.

We connect naturally sick pets to clinical trials just like in human trials, replacing induced artificial diseases in lab animals. Pets get access to cutting edge treatments for free while also helping advance cures for people.  ​

​Treatment options are scarce and very costly to pet parents. Our Clinical Trial solution offers sick pets free treatment and furthers research for humans at the same time.

Our approach

Similar to the Human Phase III Trial method, we conduct multicentric efficacy trials by recruiting already ill patients. We coordinate studies at leading veterinary schools and animal hospitals in the United States and work exclusively with top veterinary specialists. 

 

Our research subjects are naturally afflicted with diseases of interest. Experimentation is an attempt to HEAL animals. Animals are sourced by veterinarians and pet owners with sick animals. These animals with naturally occurring diseases reduce the need for laboratory animals while providing better models of disease. 

The research is compelling 

The canine genome was mapped in 2005, marking a turning point in canine to human translation. Today, our scientific collaborators are mapping the canine immune system, while integrating genomic, proteomic and epigenetic data. Leveraging the progressively annotated canine genome allows us to have access to the real-time molecular profiling of canine samples to build disease signatures for diagnostic, therapeutic and prognostic purposes. 

Pets share an environment and 350+ diseases with their human caretakers. Many naturally occurring diseases are biologically and clinically similar to human diseases,  and are also difficult to replicate in laboratory animals.

 

Dogs and cats have breed-determined limited genetic backgrounds, further improving their predictive power and value for modeling human disease.  More than 6 million companion dogs are diagnosed annually in the United States. The number of proxies is myriad. To name a few: Cavalier King Charles suffer from vascular septal defects. Lhasa Apsos and male cats develop bladder stones. Poodles are frequently afflicted by cataracts. 

DISCLAIMER: FidoCure™ is a leader in oncology research for dogs, and our team is committed to the breakthroughs in cancer biology to evolve canine cancer care, with each patient improving the outcomes for all future canine cancer patients. We use our best efforts to inform the veterinarian, who then decides which option is best for their patient. The therapies that veterinarians may prescribe and order from compounding pharmacies after receiving genetic test results from FidoCure, may constitute extra-label uses of those drugs. FidoCure is continuing to gather research data in support of novel oncology therapeutics in dogs.

  • Instagram - White Circle
  • Twitter - White Circle
  • Facebook - White Circle

© One Health Company 2019